Proteome Sciences plc

Research Proteome Sciences plc (PI2) on Bullrun: market cap EUR 4.28M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 4.28M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025GBP 3.76M-GBP 3.06M-GBP 143.00K-2.2%n/aGBP 781.00KGBP 15.77M-GBP 9.53M
FY2024GBP 4.89M-GBP 3.41M-GBP 1.05M13.7%-0.01GBP 1.13MGBP 14.52M-GBP 6.62M
FY2023GBP 5.03M-GBP 2.44M-GBP 718.00K32.8%-0.01GBP 2.03MGBP 13.48M-GBP 3.07M
FY2022GBP 7.78MGBP 1.33MGBP 1.82M61.3%0GBP 3.99MGBP 11.92M-GBP 843.00K
FY2021n/an/an/an/a0n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-27EUR 4.28Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Proteome Sciences plc

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Proteome Sciences plc's market cap?

Proteome Sciences plc's market capitalization is EUR 4.28M.

What does Proteome Sciences plc do?

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.